Tissue engineered cancer metastases as cancer vaccine to improve cancer immunotherapy is a research paper published in Acta Biomaterialia (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: R01 GM130590
National Institutes of Health
Grant: R01EB25651
U.S. Department of Defense
University of North Carolina Wilmington
CDMRP
FWCI
0.30
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals